Clinical Trials on Corona Virus Disease 2019,COVID-19

Total 7968 results

University of Lahore

Completed

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Corona Virus Disease 2019 (COVID-19)

Pakistan
Beijing 302 Hospital
Maternal and Child Health Hospital of Hubei Province; Huoshenshan Hospital; VCANBIO... and other collaborators

Completed

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Corona Virus Disease 2019(COVID-19)

China
Yu Qin

Enrolling by invitation

Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

Corona Virus Disease 2019(COVID-19)

China
AudibleHealth AI, Inc.
Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... and other collaborators

Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

Coronavirus Disease 2019 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19 | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease

United States
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Henan Provincial People's Hospital

Unknown

Tetrandrine Tablets Used in the Treatment of COVID-19 (TT-NPC)

Corona Virus Disease 2019,COVID-19

China
Murdoch Childrens Research Institute
Bill and Melinda Gates Foundation; Royal Children's Hospital

Completed

BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE)

COVID-19 | Corona Virus Infection | Coronavirus Disease 2019 (COVID-19) | Respiratory Illness

Australia, Brazil, Netherlands, Spain, United Kingdom
Peking University First Hospital

Unknown

Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive

COVID-19

China
Peking University First Hospital

Unknown

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

COVID-19

China
Southeast University, China
Hohhot First Hospital

Recruiting

Graphene Photothermal Adjuvant Therapy for Mild Corona Virus Disease 2019: A Prospective Randomized Controlled Trial

COVID-19

China
Peking University First Hospital

Unknown

Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019

COVID-19

China
Akesobio Australia Pty Ltd

Completed

A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

Coronavirus Disease 2019 (COVID-19)

New Zealand
AstraZeneca

Terminated

Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Germany
Tang-Du Hospital

Completed

Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

Coronavirus Disease 2019 (COVID-19)

China
Sinocelltech Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Coronavirus Disease 2019(COVID-19)

China
CSL Behring

Terminated

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Coronavirus Disease 2019 (COVID-19)

Australia
Janssen Vaccines & Prevention B.V.

Completed

A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive (HORIZON 2)

Coronavirus Disease-2019 (COVID-19) Prevention

South Africa, Brazil, Argentina, Mexico, India
CSL Behring

Completed

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

United States
Guangzhou Institute of Respiratory Disease
Tongji Hospital; Guangzhou Eighth People's Hospital; Guangzhou Cellgenes Biotechnology...

Unknown

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

China
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Center for Outcomes...

Suspended

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

COVID-19 | Corona Virus Infection | SARS-CoV-2 | 2019-nCoV | 2019 Novel Coronavirus

United States
Egyptian Center for Research and Regenerative Medicine
Cairo University; National Research Centre, Egypt; Academy of Scientific Research...

Completed

Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

COVID | Corona Virus Infection

Egypt
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 COVID-19

United States
Prothione, LLC

Completed

A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Rwanda
CSL Behring

Withdrawn

CSL324 in COVID-19

Coronavirus Disease 2019 (COVID-19)
Materia Medica Holding

Active, not recruiting

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Coronavirus Disease 2019 (COVID-19)

Russian Federation
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Coronavirus Disease 2019 (COVID-19)

China
Tychan Pte Ltd.

Completed

Safety of TY027, a Treatment for COVID-19, in Humans

Coronavirus Disease-2019 (COVID-19)

Singapore
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

CoronaVirus Disease-2019 (COVID-19)

United States, Hungary, Israel, Netherlands, Puerto Rico
Janssen Research & Development, LLC

Terminated

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (PREVENT-HD)

Coronavirus Disease 2019 (COVID-19)

United States
National Institute of Allergy and Infectious Diseases...

Completed

Collection of Anti-SARS-CoV-2 Immune Plasma (NIAID)

Coronavirus Disease 2019 (COVID-19)

United States
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Healthy Volunteer | Coronavirus Disease 2019 (COVID-19)

China
Fundacion Clinica Valle del Lili
Universidad Autonoma de Occidente

Completed

Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs (RedNeumon)

COVID-19 Pneumonia | COVID-19 (Coronavirus Disease 2019)

Colombia
University Hospital, Akershus

Active, not recruiting

Norwegian Coronavirus Disease 2019 Study (NO COVID-19)

Corona Virus Infection

Norway
Emmanouil D. Zacharakis

Recruiting

Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.

COVID-19 (Coronavirus Disease 2019)

Greece
Beijing Ditan Hospital

Completed

A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

Coronavirus Disease 2019(COVID-19)

China
Guangdong Raynovent Biotech Co., Ltd

Completed

The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants

COVID-19 (Coronavirus Disease 2019)

China
Tychan Pte Ltd.

Terminated

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Coronavirus Disease-2019 (COVID-19)

Singapore
Henan Provincial People's Hospital

Unknown

Sequential Oxygen Therapy Strategy for Patients With COVID-19 (SOTSPC)

Coronavirus Disease-2019

China
University of Cologne

Recruiting

Kidney in Coronavirus Disease 2019 Registry (KidneyCOVID19)

SARS-CoV 2 | Corona Virus Infection

Germany
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

COVID-19 (Coronavirus Disease 2019)

United States
Volgograd State Medical University

Active, not recruiting

Thrombohemorrhagic Complications of COVID-19

COVID-19 (Coronavirus Disease 2019)

Russian Federation
AstraZeneca

Terminated

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (ENDURE)

Coronavirus Disease 2019 (COVID-19)

United States
Abu Dhabi Stem Cells Center

Completed

Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (SENTAD-COVID)

Coronavirus Disease 2019 (COVID-19)

United Arab Emirates
Lifefactors Zona Franca, SAS

Unknown

Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.

Coronavirus Disease 2019 (COVID-19)

Colombia
Fuzhou General Hospital

Unknown

Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019

COVID-19 Pneumonia

China
University of Baghdad

Completed

Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection

COVID-19 Pandemic

Iraq
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States

Clinical Trials on Corona Virus Disease 2019,COVID-19

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations